Showing results (191-200 of 197) with videos related to
Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 197 results.
Signal Transduction and Targeted Therapy|March 20, 2026
SHR-A1811, a novel HER2-targeting antibody-drug conjugate, in advanced solid tumors (HORIZON-X): a global phase 1 trialHerui Yao, Min Yan, Zhongsheng Tong, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2024
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2-Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2-Expressing or Mutated Advanced Solid Tumors: A Global Phase I TrialHerui Yao, Min Yan, Zhongsheng Tong, et al.Annals of the New York Academy of Sciences|December 1, 2021
Cancer stem cells: advances in biology and clinical translation-a Keystone Symposia reportJennifer Cable, Duanqing Pei, Lola M Reid, et al.The Lancet. Oncology|July 1, 2026
Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trialHerui Yao, Qingyuan Zhang, Huiping Li, et al.The Lancet. Oncology|November 27, 2025
Fuzuloparib with or without apatinib in patients with HER2-negative metastatic breast cancer with germline BRCA1/2 mutations (FABULOUS): interim analysis of a multicentre, three-arm, open-label, randomised, phase 3 trialHuiping Li, Jieqiong Liu, Quchang Ouyang, et al.Annals of the New York Academy of Sciences|November 18, 2021
Noncoding RNAs: biology and applications-a Keystone Symposia reportJennifer Cable, Edith Heard, Tetsuro Hirose, et al.Nature|December 11, 2024
π-HuB: the proteomic navigator of the human bodyFuchu He, Ruedi Aebersold, Mark S Baker, et al.Pageof 20